AJMC Staff

Researchers at the University of Michigan Medical School have developed a map of the United States highlighting significant variation in stroke care.

The number of Medicare Advantage plans with $0 premiums has been on the decline since 2011, and dropped from 813 in 2014 to 726 in 2015, according to a recent analysis government data by HealthPocket.

The King v. Burwell decision to uphold subsidies on the federal marketplace is a win for patients who might have lost their mental health insurance coverage.

A pediatric long-term care facility in New York initiated an antibiotic-stewardship program to regulate the unnecessary prescribing of antibiotics.

The Core Quality Measures Collaborative Workgroup, initiated by AHIP and payer organizations, seeks to reduce, refine, and relate the healthcare delivery process.

The JAMA authors recommend that HHS and the US Department of Agriculture pay attention to DGAC's recommendations on fat intake, which do not include an upper limit on total fat consumption.

A clinical trial at the University of Alabama will be enrolling patients in the first-ever study of an open-label placebo in cancer.

Among the 20 chronic conditions with the highest impact on the Medicare population, some have no quality measure, which limits Medicare's ability to pay for value.

When evaluating the cost-effectiveness of 4 different interventions to prevent or reduce childhood obesity, researchers found that the benefit of these interventions surpassed the current clinical interventions to treat obesity.

A researcher from the University of Missouri and her team, studied the impact of closure of a large, safety-net agency on it's clients and on smaller agencies to which the clients were referred.

Although drug development is expensive, the high prices being charged for some specialty drugs, like Sovaldi, are not required to induce innovation, Len M. Nichols, PhD, wrote Monday for Morning Consult.

A study published in the New England Journal of Medicine says a CT scan following a first venous thromboebolism event may not benefit in detecting cancer.

Using mass-spectrometry—based phosphoproteomics, researchers at the Moffit Cancer Center have identified a mechanism by which BRAF/PTEN-null melanoma cells develop resistance to BRAF inhibitors.

While the concept of informed consent it a good one, there is a fundamental problem with the informed consent and how it is practiced today, writes Harlan Krumholz, MD, SM, professor of cardiology, epidemiology, and public health.